Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?
Abbott's $7.4B free cash flow and 0.3x debt load contrast sharply with UnitedHealth's $16.1B free cash flow but higher leverage and government policy risk.
Abbott Laboratories and UnitedHealth Group represent two distinct approaches to healthcare investment. Abbott Laboratories, a medical technology company, focuses on innovation in diagnostics and medical devices. In contrast, UnitedHealth Group operates a vast insurance and health services network. Both companies boast substantial market presence but operate under different risk profiles and growth trajectories.
Understanding their financials and strategic moves can help investors determine which aligns better with their investment objectives for 2026.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
